In Vitro Selections of Mammaglobin A and Mammaglobin B Aptamers for the Recognition of Circulating Breast Tumor Cells

Overview

Journal Sci Rep

Specialty Science

Date 2017 Nov 5

PMID 29101327

Citations 8

Authors

Eman M Hassan

William G Willmore

Bruce C McKay

Maria C DeRosa

Affiliations

Soon will be listed here.

Abstract

Mammaglobin B (MGB2) and mammaglobin A (MGB1) are proteins expressed in metastatic breast cancers. The early detection of circulating tumor cells (CTCs) in breast cancer patients is crucial to decrease mortality rate. Herein, novel aptamers were successfully selected and characterized against MGB2 and MGB1 proteins using a hybrid SELEX approach. The potential use of the selected aptamers in breast CTC detection was studied using spiked breast cancer cells in whole blood lysate. The results obtained from this study showed that the selected aptamers (MAMB1 and MAMA2) bind to their target breast cancer cell lines with high affinity (low nanomolar K values) and specificity. They also bind to their free recombinant target proteins and show minimal non-specific binding to normal and other cancer cell lines. Additionally, they were able to distinguish a low number of breast cancer cells spiked in whole blood lysate containing normal blood cells. The results obtained in this study indicate the great potential for the use of aptamers to detect MGB1 and MGB2 protein biomarkers, expressed on the surface of breast CTCs.

Citing Articles

Development of DNA aptamers targeting B7H3 by hybrid-SELEX: an alternative to antibodies for immuno-assays.

Maradani B, Parameswaran S, Subramanian K Sci Rep. 2024; 14(1):13552.

PMID: 38866941 PMC: 11169341. DOI: 10.1038/s41598-024-64559-7.

Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression.

Lu T, Zheng C, Fan Z Pharm Biol. 2022; 60(1):1011-1021.

PMID: 35645356 PMC: 9154753. DOI: 10.1080/13880209.2022.2069823.

Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay.

Meijer S, Klebanov-Akopyn O, Pavlov V, Laks S, Hazzan D, Nissan A Breast Cancer (Dove Med Press). 2021; 13:617-624.

PMID: 34815711 PMC: 8605792. DOI: 10.2147/BCTT.S337075.

DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing.

Kolm C, Cervenka I, Aschl U, Baumann N, Jakwerth S, Krska R Sci Rep. 2020; 10(1):20917.

PMID: 33262379 PMC: 7708460. DOI: 10.1038/s41598-020-77221-9.

HER2 biosensing through SPR-envelope tracking in plasmonic optical fiber gratings.

Lobry M, Loyez M, Chah K, Hassan E, Goormaghtigh E, DeRosa M Biomed Opt Express. 2020; 11(9):4862-4871.

PMID: 33014586 PMC: 7510885. DOI: 10.1364/BOE.401200.

References

Aristizabal-Pachon A, Carvalho T, Carrara H, de Andrade J, Takahashi C . Detection of human mammaglobin A mRNA in peripheral blood of breast cancer patients before treatment and association with metastasis. J Egypt Natl Canc Inst. 2015; 27(4):217-22. DOI: 10.1016/j.jnci.2015.09.003. View

Gedi V, Kim Y . Detection and characterization of cancer cells and pathogenic bacteria using aptamer-based nano-conjugates. Sensors (Basel). 2014; 14(10):18302-27. PMC: 4239906. DOI: 10.3390/s141018302. View

Ballestrero A, Garuti A, Bertolotto M, Rocco I, Boy D, Nencioni A . Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer. 2005; 92(10):1948-52. PMC: 2361769. DOI: 10.1038/sj.bjc.6602563. View

Redig A, McAllister S . Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013; 274(2):113-26. PMC: 3711134. DOI: 10.1111/joim.12084. View

Zehentner B, Carter D . Mammaglobin: a candidate diagnostic marker for breast cancer. Clin Biochem. 2004; 37(4):249-57. DOI: 10.1016/j.clinbiochem.2003.11.005. View

Sefah K, Tang Z, Shangguan D, Chen H, Lopez-Colon D, Li Y . Molecular recognition of acute myeloid leukemia using aptamers. Leukemia. 2009; 23(2):235-44. PMC: 2640431. DOI: 10.1038/leu.2008.335. View

Graham F, Smiley J, Russell W, Nairn R . Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977; 36(1):59-74. DOI: 10.1099/0022-1317-36-1-59. View

Klug J, Beier H, Bernard A, Chilton B, Fleming T, Lehrer R . Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci. 2001; 923:348-54. DOI: 10.1111/j.1749-6632.2000.tb05549.x. View

Bellone S, Tassi R, Betti M, English D, Cocco E, Gasparrini S . Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy. Br J Cancer. 2013; 109(2):462-71. PMC: 3721400. DOI: 10.1038/bjc.2013.315. View

10.

Toh S, Citartan M, Gopinath S, Tang T . Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosens Bioelectron. 2014; 64:392-403. DOI: 10.1016/j.bios.2014.09.026. View

11.

Walsh R, DeRosa M . Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun. 2009; 388(4):732-5. DOI: 10.1016/j.bbrc.2009.08.084. View

12.

Lehrer R, Xu G, Abduragimov A, Dinh N, Qu X, Martin D . Lipophilin, a novel heterodimeric protein of human tears. FEBS Lett. 1998; 432(3):163-7. DOI: 10.1016/s0014-5793(98)00852-7. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Sun H, Zhu X, Lu P, Rosato R, Tan W, Zu Y . Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids. 2014; 3:e182. PMC: 4221593. DOI: 10.1038/mtna.2014.32. View

15.

Shangguan D, Li Y, Tang Z, Cao Z, Chen H, Mallikaratchy P . Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006; 103(32):11838-43. PMC: 1567664. DOI: 10.1073/pnas.0602615103. View

16.

Jackson B, Thompson D, Wright M, McAndrews M, Bernard A, Nebert D . Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics. 2011; 5(6):691-702. PMC: 3251818. DOI: 10.1186/1479-7364-5-6-691. View

17.

BECKER R, Darrow C, Zimonjic D, Popescu N, Watson M, Fleming T . Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics. 1998; 54(1):70-8. DOI: 10.1006/geno.1998.5539. View

18.

Zhao C, Nguyen T, Yusifov T, Glasgow B, Lehrer R . Lipophilins: human peptides homologous to rat prostatein. Biochem Biophys Res Commun. 1999; 256(1):147-55. DOI: 10.1006/bbrc.1999.0274. View

19.

Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D . Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol. 1999; 17(7):2015-9. DOI: 10.1200/JCO.1999.17.7.2015. View

20.

Hicke B, Marion C, Chang Y, Gould T, Lynott C, Parma D . Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem. 2001; 276(52):48644-54. DOI: 10.1074/jbc.M104651200. View